Recent advances in AI enable researchers to mine social media for large-scale, real-world data on prescription drugs. Their ...
Obesity in Kenya is still often spoken about as a character flaw. A question of discipline. Even gluttony. Yet science and ...
GLP-1 drugs are reshaping the lives of many, but such treatments can come with a side order of stigma, even shame ...
Why the Compliance Answer You’re Getting May Not Be the Answer You Need- If your company offers health benefits, someone has ...
AI-enabled research shifts decision-making to late-night online moments; brands must engage when intent crystallizes and ...
Q3 reiterated FY 2026 gross margin range “62% to 63%” (CFO Sandercock), consistent with Q2’s updated FY 2026 gross margin range.
Who needs more than two employees when artificial intelligence can do so many corporate tasks? It’s super efficient — and a ...
At the AXS26 Summit, Wheel’s Chris Moose argued that pharmaceutical companies must abandon outdated, prescription-focused engagement models and meet patients earlier in their decision-making process.
Good afternoon, everyone, and welcome to our first quarter of 2026 earnings call. Bob Bradway will lead the call today and be followed by a broader review of our performance by Murdo Gordon, Jay ...
With new data showing that UK healthy life expectancy has dropped, Food Manufacture’s editor looks at the drivers behind the ...
US regulators move to restrict compounded weight-loss drugs, tightening control over Ozempic and Wegovy alternatives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results